242 related articles for article (PubMed ID: 23291003)
1. Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling.
Chandrasekera PC; Wan TC; Gizewski ET; Auchampach JA; Lasley RD
Cell Signal; 2013 Apr; 25(4):736-42. PubMed ID: 23291003
[TBL] [Abstract][Full Text] [Related]
2. Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy.
Lavoie C; Mercier JF; Salahpour A; Umapathy D; Breit A; Villeneuve LR; Zhu WZ; Xiao RP; Lakatta EG; Bouvier M; Hébert TE
J Biol Chem; 2002 Sep; 277(38):35402-10. PubMed ID: 12140284
[TBL] [Abstract][Full Text] [Related]
3. Hetero-oligomerization between adenosine A₁ and thromboxane A₂ receptors and cellular signal transduction on stimulation with high and low concentrations of agonists for both receptors.
Mizuno N; Suzuki T; Hirasawa N; Nakahata N
Eur J Pharmacol; 2012 Feb; 677(1-3):5-14. PubMed ID: 22200626
[TBL] [Abstract][Full Text] [Related]
4. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Loop 2 of the Adenosine A1 Receptor Has a Key Role in Orthosteric Ligand Affinity and Agonist Efficacy.
Nguyen AT; Baltos JA; Thomas T; Nguyen TD; Muñoz LL; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
Mol Pharmacol; 2016 Dec; 90(6):703-714. PubMed ID: 27683014
[TBL] [Abstract][Full Text] [Related]
6. β-Adrenergic regulation of cardiac progenitor cell death versus survival and proliferation.
Khan M; Mohsin S; Avitabile D; Siddiqi S; Nguyen J; Wallach K; Quijada P; McGregor M; Gude N; Alvarez R; Tilley DG; Koch WJ; Sussman MA
Circ Res; 2013 Feb; 112(3):476-86. PubMed ID: 23243208
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between adenosine A1 and β1-adrenergic receptors regulates translocation of PKCε in isolated rat cardiomyocytes.
Komatsu S; Dobson JG; Ikebe M; Shea LG; Fenton RA
J Cell Physiol; 2012 Sep; 227(9):3201-7. PubMed ID: 22105697
[TBL] [Abstract][Full Text] [Related]
8. Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation.
Jordan BA; Trapaidze N; Gomes I; Nivarthi R; Devi LA
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):343-8. PubMed ID: 11134510
[TBL] [Abstract][Full Text] [Related]
9. The third intracellular loop and the carboxyl terminus of beta2-adrenergic receptor confer spontaneous activity of the receptor.
Chakir K; Xiang Y; Yang D; Zhang SJ; Cheng H; Kobilka BK; Xiao RP
Mol Pharmacol; 2003 Nov; 64(5):1048-58. PubMed ID: 14573753
[TBL] [Abstract][Full Text] [Related]
10. Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties.
Breit A; Lagacé M; Bouvier M
J Biol Chem; 2004 Jul; 279(27):28756-65. PubMed ID: 15123695
[TBL] [Abstract][Full Text] [Related]
11. Receptor specific crosstalk and modulation of signaling upon heterodimerization between β1-adrenergic receptor and somatostatin receptor-5.
Somvanshi RK; War SA; Chaudhari N; Qiu X; Kumar U
Cell Signal; 2011 May; 23(5):794-811. PubMed ID: 21238583
[TBL] [Abstract][Full Text] [Related]
12. Biochemical assay of G protein-coupled receptor oligomerization: adenosine A1 and thromboxane A2 receptors form the novel functional hetero-oligomer.
Mizuno N; Suzuki T; Kishimoto Y; Hirasawa N
Methods Cell Biol; 2013; 117():213-27. PubMed ID: 24143980
[TBL] [Abstract][Full Text] [Related]
13. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
[TBL] [Abstract][Full Text] [Related]
14. Effect of linker length and composition on heterobivalent ligand-mediated receptor cross-talk between the A1 adenosine and β2 adrenergic receptors.
Barlow N; Baker SP; Scammells PJ
ChemMedChem; 2013 Dec; 8(12):2036-46. PubMed ID: 24106065
[TBL] [Abstract][Full Text] [Related]
15. NanoBiT Complementation to Monitor Agonist-Induced Adenosine A
Soave M; Kellam B; Woolard J; Briddon SJ; Hill SJ
SLAS Discov; 2020 Feb; 25(2):186-194. PubMed ID: 31583945
[TBL] [Abstract][Full Text] [Related]
16. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions.
Nasrollahi-Shirazi S; Sucic S; Yang Q; Freissmuth M; Nanoff C
J Pharmacol Exp Ther; 2016 Oct; 359(1):73-81. PubMed ID: 27451411
[TBL] [Abstract][Full Text] [Related]
18. Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy.
Galandrin S; Bouvier M
Mol Pharmacol; 2006 Nov; 70(5):1575-84. PubMed ID: 16901982
[TBL] [Abstract][Full Text] [Related]
19. Effects of milrinone on contractility and cyclic adenosine monophosphate production induced by beta1- and beta2-adrenergic receptor activation in human myocardium.
Carceles MD; Fuentes T; Aroca V; Lopez J; Hernández J
Clin Ther; 2007 Aug; 29(8):1718-24. PubMed ID: 17919552
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial over-expression of soluble epoxide hydrolase (Tie2-sEH) enhances adenosine A
Yadav VR; Hong KL; Zeldin DC; Nayeem MA
Mol Cell Biochem; 2016 Nov; 422(1-2):197-206. PubMed ID: 27629787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
